Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Overactive bladder (adults) (Propiverine hydrochloride - Overactive bladder (adults))

Records returned : 19 (on 29 May 2025 at 11:11:08). Return to search results for ' Overactive bladder (adults) '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

Drug:

Indication :

Overactive bladder (adults)

Status :

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

2. Propiverine hydrochloride

Drug:

Propiverine hydrochloride

Indication :

Overactive bladder (adults)

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

3. Solifenacin

Drug:

Solifenacin

Indication :

Overactive bladder (adults)

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

1st line unless contra-indicated

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

7. Solifenacin

Drug:

Solifenacin

Indication :

Overactive bladder (adults)

Status :

Green (see narrative)

Formulations :

Oral suspension

Restrictions / Comments:

Important

Only for patients with swallowing difficulties. Prescribe as solifenacin 1mg/ml oral SUSPENSION

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

17. Solifenacin

Drug:

Solifenacin

Indication :

Overactive bladder (adults)

Status :

Non Formulary

Formulations :

Oral solution

Restrictions / Comments:

Important

Prescribe as solifenacin 1mg/ml oral SUSPENSION

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

4. Fesoterodine fumarate

Drug:

Fesoterodine fumarate

Indication :

Overactive bladder (adults)

Status :

Green (see narrative)

Formulations :

Not Specified

Restrictions / Comments:

Important

3rd line - for patients requiring more potent treatment

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

5. Mirabegron

Drug:

Mirabegron

Indication :

Overactive bladder (adults)

Status :

Green (see narrative)

Formulations :

Not Specified

Restrictions / Comments:

Important

Solifenacin is 1st line. Mirabegron for use when antimuscarinics are contraindicated, patients with CNS adverse effects or patients requiring a more potent treatment.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

6. Oxybutynin

Drug:

Oxybutynin

Indication :

Overactive bladder (adults)

Status :

Green (see narrative)

Formulations :

Patches

Restrictions / Comments:

Important

Solifenacin 1mg/ml oral SUSPENSION is preferred for patients with swallowing difficulties. Oxybutynin patches are reserved for patients where an oral formulation is not suitable

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

16. Oxybutynin

Drug:

Oxybutynin

Indication :

Overactive bladder (adults)

Status :

Non Formulary

Formulations :

Modified release tablets
Oral solution
Tablets

Restrictions / Comments:

Important

Switch to solifenacin recommended (if appropriate).

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

19. Oxybutynin

Drug:

Oxybutynin

Indication :

Overactive bladder (adults)

Status :

See narrative

Formulations :

Intravesical

Restrictions / Comments:

Important

This drug has not yet been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an application to the APC.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD2

8. Tolterodine

Drug:

Tolterodine

Indication :

Overactive bladder (adults)

Status :

Green (see narrative)

Formulations :

Immediate release tablets

Restrictions / Comments:

Important

1st line in patients with renal impairment

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

18. Tolterodine

Drug:

Tolterodine

Indication :

Overactive bladder (adults)

Status :

Non Formulary

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Switch to solifenacin (or formulary alternative) recommended

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

9. Trospium chloride

Drug:

Trospium chloride

Indication :

Overactive bladder (adults)

Status :

Green (see narrative)

Formulations :

Immediate release tablets

Restrictions / Comments:

Important

Alternative 1st line in patients where anticholinergic burden is a problem or on medicines that interact.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

10. Trospium chloride

Drug:

Trospium chloride

Indication :

Overactive bladder (adults)

Status :

Green (see narrative)

Formulations :

Modified release tablets

Restrictions / Comments:

Important

2nd line in patients where anticholinergic burden is a problem or on medicines that interact.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

11. Vibegron

Drug:

Vibegron

Indication :

Overactive bladder (adults)

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Mirabegron is the preferred option where an antimuscarinic is not suitable. Vibegron should have a very limited place in therapy.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

12. Botulinum toxin type A

Drug:

Botulinum toxin type A

Indication :

Overactive bladder (adults)

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Important

RSFT: Urology Only
SASH: Botox only. Urology Only

NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

13. Darifenacin hydrobromide

Drug:

Darifenacin hydrobromide

Indication :

Overactive bladder (adults)

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Important

Switch to solifenacin recommended (if appropriate)

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

14. Flavoxate hydrochloride

Drug:

Flavoxate hydrochloride

Indication :

Overactive bladder (adults)

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

15. Imipramine hydrochloride

Drug:

Imipramine hydrochloride

Indication :

Overactive bladder (adults)

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1